Unión Europea - español - EMA (European Medicines Agency)

astrazeneca ab - tezepelumab - asma - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

astrazeneca peru s.a. - droguerÍa - solucion inyectable - por jeringa precargada 1.91 ml - - tezepelumab